Predictors of Outcome after Endovascular Treatment of Cerebral Vasospasm

References

1. ↵
   Barnwell SL, Higashida RT, Halbach VV, Dowd CF, Wilson CB, Hieshima GB. Transluminal angioplasty of intracerebral vessels for cerebral arterial spasm: reversal of neurological deficits after delayed treatment. Neurosurgery 1989;25:424–429

   PubMed
2. Barreau X, Pastore M, Piotin M, Spelle C, Moret J. Endovascular treatment of cerebral vasospasm following SAH. Acta Neurochir Suppl 2001;77:177–180
3. ↵
   Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998;42:979–986

   PubMedWeb of Science
4. Bracard S, Picard L, Marchal JC, et al. Role of angioplasty in the treatment of symptomatic vascular spasm occurring in the post-operative course of intracranial ruptured aneurysms. J Neuroradiol 1990;17:6–19

   PubMed
5. ↵
   Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998;42:510–516

   CrossRefPubMedWeb of Science
6. Higashida RT, Halbach VV, Cahan LD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989;71:648–653

   PubMedWeb of Science
7. Kaku Y, Yonekawa Y, Tsukahara T, Kaxekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77:842–847

   PubMedWeb of Science
8. ↵
   Katoh H, Shima K, Shimizu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999;21:195–203

   PubMed
9. Newell DW, Eskridge JM, Aaslid R. Current indications and results of cerebral angioplasty. Acta Neurochir Suppl 2001;77:181–183
10. ↵
    Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien 1984;70:65–79

    CrossRefPubMed
11. ↵
    Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284–290

    PubMedWeb of Science
12. ↵
    Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–1264

    CrossRefPubMedWeb of Science
13. ↵
    Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST. The prophylactic use of transluminal balloon angioplasty in patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999;91:51–58

    PubMedWeb of Science
14. ↵
    Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975–979

    PubMedWeb of Science
15. ↵
    Carter BS, Buckley D, Ferraro R, Rordorf G, Ogilvy CS. Factors associated with reintegration to normal living after subarachnoid hemorrhage. Neurosurgery 2000;46:1326–1333

    CrossRefPubMedWeb of Science
16. ↵
    Lanzino G, Kassell NF, Germanson TP, et al. Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg 1996;85:410–418

    PubMedWeb of Science
17. ↵
    Charpentier C, Audibert G, Guillemin F, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999;30:1402–1408

    Abstract/FREE Full Text
18. Torbey MT, Hauser TK, Bhardwaj A, et al. Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2001;32:2005–2011

    Abstract/FREE Full Text
19. ↵
    Macdonald RL, Rosengart A, Huo D, Karrison T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 2003;99:644–652

    PubMed
20. ↵
    Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–284

    PubMedWeb of Science
21. ↵
    Kobayashi H, Ide H, Aradachi H, Arai Y, Handa Y, Kubota T. Histological studies of intracranial vessels in primates following transluminal angioplasty for vasospasm. J Neurosurg 1993;78:481–486

    PubMed
22. ↵
    Chan PD, Findlay JM, Vollrath B, et al. Pharmacological and morphological effects of in vitro transluminal balloon angioplasty on normal and vasospastic canine basilar arteries. J Neurosurg 1995;83:522–530

    PubMed
23. ↵
    Kuwayama A, Zervas NT, Shintani A, Pickren KS. Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm. Stroke 1972;3:27–33

    Abstract/FREE Full Text
24. ↵
    Ogata M, Marshall BM, Lougheed WM. Observations on the effects of intrathecal papaverine in experimental vasospasm. J Neurosurg 1973;38:20–25

    PubMed
25. ↵
    Nakajima M, Date I, Takahashi K, Ninomiya Y, Asari S, Ohmoto T. Effects of aging on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 2001;32:620–628

    Abstract/FREE Full Text
26. ↵
    Linskey ME, Horton JA, Rao GR, Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage: case report. J Neurosurg 1991;74:985–990

    PubMedWeb of Science
27. ↵
    Volk EE, Prayson RA, Perl J II. Autopsy findings of fatal complication of posterior cerebral circulation angioplasty. Arch Pathol Lab Med 1997;121:738–740

    PubMed
28. ↵
    Srinivasan J, Moore A, Eskridge J, Winn HR, Newell DW. Long-term follow up of angioplasty for cerebral vasospasm. Acta Neurochir Suppl 2001;77:195–197